Keywords: Mexico, Markets, Production, Generics, Biosimilars

While weakening of Mexico’s peso is causing problems, generics will fuel pharma market growth

Article | 25 February 2010

Print This

The exchange rate of the Mexican peso against the US dollar is causing uncertainty, with increasing pharmaceutical import costs, according ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in